Scheme of Amalgamation

13-12-2018: The Scheme of Amalgamation between the Company and GlaxoSmithKline Consumer Healthcare Limited (GSK CH), and their respective shareholders and creditors, pursuant to the provisions of Sections 230 to 232 and other applicable provisions of Companies Act, 2013, approved by the Board of Directors in their meeting held on 3rd December, 2018 has been submitted with National Stock Exchange of India Limited and BSE Limited.

Back to top


We're always looking to connect with those who share an interest in a sustainable future.


Get in touch with Unilever and specialist teams in our headquarters or find contacts around the world.

Contacting us